Related Experiment Video
Updated: Jul 18, 2026

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions
Published on: April 21, 2016
Prevention of transthyretin amyloid disease by changing protein misfolding energetics
Per Hammarström1, R Luke Wiseman, Evan T Powers
1Department of Chemistry and The Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Abstract:
Genetic evidence suggests that inhibition of amyloid fibril formation by small molecules should be effective against amyloid diseases. Known amyloid inhibitors appear to function by shifting the aggregation equilibrium away from the amyloid state. Here, we describe a series of transthyretin amyloidosis inhibitors that functioned by increasing the kinetic barrier associated with misfolding, preventing amyloidogenesis by stabilizing the native state. The trans-suppressor mutation, threonine 119 --> methionine 119, which is known to ameliorate familial amyloid disease, also functioned through kinetic stabilization, implying that this small-molecule strategy should be effective in treating amyloid diseases.
Insights
Small molecules can treat amyloid diseases by stabilizing the native protein state, preventing harmful amyloid fibril formation. This kinetic stabilization strategy is effective for transthyretin amyloidosis and potentially other amyloid diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Amyloid diseases are linked to the formation of amyloid fibrils.
- Current amyloid inhibitors shift aggregation equilibrium away from the amyloid state.
- Genetic evidence suggests small molecule inhibition of amyloid fibril formation is a viable therapeutic strategy.
Purpose of the Study:
- To describe novel transthyretin amyloidosis inhibitors.
- To investigate the mechanism of action for these inhibitors.
- To explore the potential of kinetic stabilization as a therapeutic strategy for amyloid diseases.
Main Methods:
- Synthesis and characterization of small molecule inhibitors.
- Assays to measure protein misfolding and amyloid formation.
- Analysis of a known trans-suppressor mutation (T119M) in transthyretin.
Main Results:
- Developed small molecules that inhibit transthyretin amyloidosis.
- These inhibitors increase the kinetic barrier of protein misfolding.
- Stabilization of the native protein state prevents amyloidogenesis.
- The T119M mutation functions via kinetic stabilization, similar to the small molecules.
Conclusions:
- Small molecules can prevent amyloid diseases by kinetically stabilizing the native protein state.
- This strategy offers a new approach for treating transthyretin amyloidosis.
- Kinetic stabilization is a promising therapeutic avenue for various amyloid diseases.
Related Concept Videos
Protein Folding
Protein Folding
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Folding Quality Check in the RER
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

